96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03220841 (ClinicalTrials.gov)	October 9, 2017	6/7/2017	Stricture Definition and Treatment (STRIDENT) Drug Therapy Study	Stricture Definition and Treatment (STRIDENT) Drug Therapy Study	Crohn Disease;Inflammatory Bowel Diseases;Stricture; Bowel	Drug: Adalimumab Injection;Drug: Thiopurine;Procedure: Endoscopic balloon dilatation	St Vincent's Hospital Melbourne	Australasian Gastro Intestinal Research Foundation;AbbVie	Active, not recruiting	18 Years	N/A	All	78	Phase 4	Australia
2	EUCTR2016-003321-42-NL (EUCTR)	18/01/2017	08/12/2016	Stepwise extention of the adalimumab injection interval in patients with stable Crohn's disease.	Lengthening Adalimumab Dosing Interval in quiescent Crohn’s disease patients: the LADI study.	Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Trade Name: Humira (adalimumab) Product Name: Adalimumab INN or Proposed INN: ADALIMUMAB	Radboud University Medical Centre	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Netherlands

First Previous1Next Last